# AET04_PI full table is produced correctly

    Code
      res
    Output
                                                                                   Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                                                 Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                    (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                            
      Total number of patients with at least one adverse event    19 (22.1%)       4 (4.7%)           0         34 (47.2%)       6 (8.3%)           0         35 (36.5%)       6 (6.2%)       2 (2.1%)  
        PRURITUS                                                       9               3              0             36               8              0             24               1              1     
        ERYTHEMA                                                      10               0              0             19               0              0             16               2              0     
        RASH                                                           6               1              0             15               1              0             14               2              0     
        SKIN IRRITATION                                                3               0              0              7               0              0              6               1              1     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                              
      Total number of patients with at least one adverse event    10 (11.6%)       2 (2.3%)           0         29 (40.3%)       5 (6.9%)           0         31 (32.3%)       8 (8.3%)           0     
        APPLICATION SITE PRURITUS                                      7               2              0             29               3              0             24               3              0     
        APPLICATION SITE ERYTHEMA                                      3               0              0             19               3              0             14               2              0     
        APPLICATION SITE IRRITATION                                    3               1              0             12               1              0              9               3              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                        
      Total number of patients with at least one adverse event     4 (4.7%)            0          1 (1.2%)      10 (13.9%)       2 (2.8%)       1 (1.4%)       6 (6.2%)        1 (1.0%)           0     
        VOMITING                                                       3               0              1              8               0              0              4               0              0     
        NAUSEA                                                         3               0              0              8               3              1              3               1              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                          
      Total number of patients with at least one adverse event     7 (8.1%)        1 (1.2%)           0          6 (8.3%)            0              0          3 (3.1%)            0              0     
        HEADACHE                                                       8               1              0              8               0              0              3               0              0     
      VASCULAR DISORDERS                                                                                                                                                                                
      Total number of patients with at least one adverse event         0               0              0          1 (1.4%)            0              0              0               0              0     
        WOUND HAEMORRHAGE                                              0               0              0              1               0              0              0               0              0     

# AET04_PI variant 1 is produced correctly

    Code
      res
    Output
                                                                               Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                                             Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                        
      PRURITUS                                                     9               3              0             36               8              0             24               1              1     
      ERYTHEMA                                                    10               0              0             19               0              0             16               2              0     
      RASH                                                         6               1              0             15               1              0             14               2              0     
      SKIN IRRITATION                                              3               0              0              7               0              0              6               1              1     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               2              0             29               3              0             24               3              0     
      APPLICATION SITE ERYTHEMA                                    3               0              0             19               3              0             14               2              0     
      APPLICATION SITE IRRITATION                                  3               1              0             12               1              0              9               3              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                    
      VOMITING                                                     3               0              1              8               0              0              4               0              0     
      NAUSEA                                                       3               0              0              8               3              1              3               1              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                      
      HEADACHE                                                     8               1              0              8               0              0              3               0              0     

# AET04_PI variant 2 is produced correctly

    Code
      res
    Output
                                                                 Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                               Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                  (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                          
      PRURITUS                                       9               3              0             36               8              0             24               1              1     
      ERYTHEMA                                      10               0              0             19               0              0             16               2              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                        
      HEADACHE                                       8               1              0              8               0              0              3               0              0     

# AET04_PI variant 3 is produced correctly

    Code
      res
    Output
                                                                               Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                                             Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                        
      PRURITUS                                                     9               3              0             36               8              0             24               1              1     
      ERYTHEMA                                                    10               0              0             19               0              0             16               2              0     
      RASH                                                         6               1              0             15               1              0             14               2              0     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               2              0             29               3              0             24               3              0     
      APPLICATION SITE ERYTHEMA                                    3               0              0             19               3              0             14               2              0     
      APPLICATION SITE IRRITATION                                  3               1              0             12               1              0              9               3              0     

# AET04_PI variant 4 is produced correctly

    Code
      res
    Output
                                                                 Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                               Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                  (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                          
      PRURITUS                                       9               3              0             36               8              0             24               1              1     

# AET04_PI variant 5 is produced correctly

    Code
      res
    Output
                                                                               Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                                             Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                        
      PRURITUS                                                     9               3              0             36               8              0             24               1              1     
      ERYTHEMA                                                    10               0              0             19               0              0             16               2              0     
      RASH                                                         6               1              0             15               1              0             14               2              0     
      SKIN IRRITATION                                              3               0              0              7               0              0              6               1              1     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               2              0             29               3              0             24               3              0     
      APPLICATION SITE ERYTHEMA                                    3               0              0             19               3              0             14               2              0     
      APPLICATION SITE IRRITATION                                  3               1              0             12               1              0              9               3              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                    
      VOMITING                                                     3               0              1              8               0              0              4               0              0     
      NAUSEA                                                       3               0              0              8               3              1              3               1              0     

# AET04_PI variant 6 is produced correctly

    Code
      res
    Output
                                                                                       Placebo                                                Xanomeline High Dose                                           Xanomeline Low Dose                    
                                                             Any Grade (%)   Grade 1-2 (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 1-2 (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 1-2 (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)          (N=86)         (N=86)         (N=72)          (N=72)          (N=72)         (N=72)         (N=96)          (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                                                                        
      PRURITUS                                                     9               6               3              0             36              28               8              0             24              22               1              1     
      ERYTHEMA                                                    10              10               0              0             19              19               0              0             16              14               2              0     
      RASH                                                         6               5               1              0             15              14               1              0             14              11               2              0     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               5               2              0             29              26               3              0             24              21               3              0     
      APPLICATION SITE ERYTHEMA                                    3               3               0              0             19              17               3              0             14              11               2              0     
      APPLICATION SITE IRRITATION                                  3               2               1              0             12              11               1              0              9               6               3              0     

# AET04_PI variant 7 is produced correctly

    Code
      res
    Output
                                                                                       Placebo                                                Xanomeline High Dose                                           Xanomeline Low Dose                    
                                                             Any Grade (%)   Grade 3-4 (%)   Grade 3-5 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 3-5 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 3-5 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)          (N=86)         (N=86)         (N=72)          (N=72)          (N=72)         (N=72)         (N=96)          (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                                                                        
      PRURITUS                                                     9               3               3              0             36               8               8              0             24               1               2              1     
      ERYTHEMA                                                    10               0               0              0             19               0               0              0             16               2               2              0     
      RASH                                                         6               1               1              0             15               1               1              0             14               2               2              0     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               2               2              0             29               3               3              0             24               3               3              0     
      APPLICATION SITE ERYTHEMA                                    3               0               0              0             19               3               3              0             14               2               2              0     
      APPLICATION SITE IRRITATION                                  3               1               1              0             12               1               1              0              9               3               3              0     

# AET04_PI variant 8 is produced correctly

    Code
      res
    Output
                                                      Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                    Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                       (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      PRURITUS                            9               3              0             36               8              0             24               1              1     
      APPLICATION SITE PRURITUS           7               2              0             29               3              0             24               3              0     
      ERYTHEMA                           10               0              0             19               0              0             16               2              0     
      APPLICATION SITE ERYTHEMA           3               0              0             19               3              0             14               2              0     
      RASH                                6               1              0             15               1              0             14               2              0     
      APPLICATION SITE IRRITATION         3               1              0             12               1              0              9               3              0     

